Regimen-related toxicity and non-relapse mortality with high-dose cyclophosphamide, carmustine (BCNU) and etoposide (VP16-213) (CBV) and CBV plus cisplatin (CBVP) followed by autologous stem cell transplantation in patients with Hodgkin’s disease-Reference-Cited by-同舟云学术

Regimen-related toxicity and non-relapse mortality with high-dose cyclophosphamide, carmustine (BCNU) and etoposide (VP16-213) (CBV) and CBV plus cisplatin (CBVP) followed by autologous stem cell transplantation in patients with Hodgkin’s disease

Published:1999-06 Issue:11 Volume:23 Page:1131-1138
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Reece DE,Nevill TJ,Sayegh A,Spinelli JJ,Brockington DA,Barnett MJ,Klingemann H-G,Connors JM,Nantel SH,Shepherd JD,Sutherland HJ,Voss NJS,Fairey RN,O’Reilly SE,Phillips GL

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1701790.pdf

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nitrogen mustards;Encyclopedia of Toxicology;2024

2. Identification of clinical factors impacting outcome in patients undergoing autologous hematopoietic cell transplantation after BEAM and TEAM conditioning;European Journal of Haematology;2023-10-12

3. Clinical analysis of bacterial infection characteristics in lymphoma patients with high-dose chemotherapy combined with autologous hematopoietic stem cell transplantation-a single-centered retrospective study;Combinatorial Chemistry & High Throughput Screening;2023-09-15

4. High-dose Bendamustine-EAM followed by autologous stem cell rescue results in long-term remission rates in lymphoma patients, without renal toxicity;European Journal of Haematology;2018-08-03

5. High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma;Bone Marrow Transplantation;2017-10-30